• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Dompe Farmaceutici`s Biologic Oxervate (cenegermin) Receives Approval in the U.S.

    20 Oct 2023 //

    FDA

    Eni and Dompe farmaceutici join forces for health research

    11 Oct 2023 //

    ECONOMIC TIMES

    Dompé farmaceutici Appoints Shannon K. Sullivan as CCO Biotech

    10 Oct 2023 //

    BUSINESSWIRE

    Dompe : New Published Data Point to Spike Protein Interactions with Estrogen

    30 Nov 2022 //

    PRNEWSWIRE

    Two Clinical Studies to Treat Mild-to-Moderate COVID-19 for Drug Design

    26 Jul 2022 //

    PRNEWSWIRE

    Dompé Announces Results of PII Study Evaluating Reparixin

    13 Jun 2022 //

    PRNEWSWIRE

    Dompé begins enrollment in Phase 3 of cenegermin in Sjögren`s-related DED

    09 Feb 2022 //

    PRNEWSWIRE

    Engitix Announces $54m Series A Financing & Strategic Collaboration

    18 Jan 2022 //

    BUSINESSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.